AmritaGen Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
AmritaGen General Information
Description
Developer of targeted exosome therapies designed to treat neurodegenerative diseases. The company engages in brain-penetrant drug delivery using genetically engineered exosomes with unrestricted gene payload capacity, low immunogenicity, and dual compatibility with gene and drug molecules, enabling clinicians to restore impaired neural activity in patients with Alzheimer's, Parkinson's, and traumatic brain injuries.
Contact Information
Website
www.amritagen.comCorporate Office
- 3500 Camp Bowie Boulevard
- Fort Worth, TX 76107
- United States
Corporate Office
- 3500 Camp Bowie Boulevard
- Fort Worth, TX 76107
- United States
AmritaGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
AmritaGen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HSC Next | Accelerator/Incubator |
AmritaGen FAQs
-
When was AmritaGen founded?
AmritaGen was founded in 2022.
-
Where is AmritaGen headquartered?
AmritaGen is headquartered in Fort Worth, TX.
-
What industry is AmritaGen in?
AmritaGen’s primary industry is Biotechnology.
-
Is AmritaGen a private or public company?
AmritaGen is a Private company.
-
What is AmritaGen’s current revenue?
The current revenue for AmritaGen is .
-
Who are AmritaGen’s investors?
HSC Next has invested in AmritaGen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process